Table 1.

Studies assessing the decrease in fibroid volume and the necrosis volume immediately after treatment in symptomatic women.

Author and Year of Publication	Patient Follow-up Time	Number of Patients	Age, Mean andStandard Deviation	Mean Reduction in Fibroid Volume	NPV Mean (%)
Park et al., 2014	3 months	79	43.6±4.4	23.1%	62.7±25.5
Kim et al., 2012	3 months	27	44.5±3.8	64.2%	64.2±19.9
Ikink et al., 2013	6 months	46	45.3±4.1	29%	40±22
LeBlang et al., 2010	6 months	80	44±3.2	31%	55±25
Morita et al., 2008	6 months	48	42.6±5.8	33%	60±18
Rabinovic et al., 2007	6 months	35	46.4±4.7	15%	31±23
Hindley et al., 2004	6 months	109	44.8±4.9	13.5%	25±6.0
Lenard et al., 2008	12 months	66	45.4±4.4	9.3%	16.3±13.3
Dobrotwir et al., 2012	12 months	74	42±7.0	38%	67±25
Wang et al., 2012*	24 months	78	38.2±6.4	90.1%	80±12
Funaki et al., 2009	24 months	91	40.4±4.6	39.5%	67±25
Kim et al., 2011	36 months	40	46±4.5	32%	32.1±6.2

NPV: nonperfused volume.

^*Study of women with submucosal fibroids.